Inhibitory Effects of OD 78 [3-(4-bromo-phenoxy)-4,5-dihydroxybenzoic acid-methyl ester] on the Proliferation and Migration of TNF-α-induced Rat Aortic Smooth Muscle Cells

다국어 초록 (Multilingual Abstract)

The proliferation and migration of vascular smooth muscle cells (VSMCs) play important roles in the formation and progression of intimal thickening in early-phase atherosclerosis and in restenosis after vascular injury. Tumor necrosis factor-α (TNF-α) is released from macrophages in atherosclerotic lesions and from neointimal vascular smooth muscle cells after balloon-injury.
Obovatol, a major biphenolic component isolated from the Magnolia obovata leaf, is known to have anti-inflammatory and antitumor activities. The goal of this study was to examine the cardioprotective effects of the obovatol derivative OD 78 on the TNF-α-induced proliferation and migration of rat aortic smooth muscle cells (RASMCs). The antiproliferative effects of OD 78 on RASMCs were examined by cell counting and [³H]-thymidine incorporation assays. Treatment of cells with 1-4 μM OD 78 inhibited the proliferation and DNA synthesis of TNF-α-stimulated RASMCs in a concentration-dependent manner, without cytotoxicity. Treatment with OD 78 inhibited TNF-α-mediated p38 phosphorylation, but did not change the activation of extracellular signal-regulated kinase or c-Jun N-terminal kinase. Furthermore, treatment with OD 78 decreased TNF-α-induced levels of cyclin E, cyclin D1, CDK2, proliferating cell nuclear antigen, and phosphorylated retinoblastoma protein, but not the CDK4 expression level. Also, OD 78 inhibits the migration of TNF-α-induced RASMC in transwells. OD 78 treatment strongly decreased matrix metalloproteinase-9 (MMP-9) expression in a dose-dependent manner, but the MMP-2 expression was unchanged. These results show that OD 78 may be developed as a potential antiproliferative agent for the treatment of angioplasty restenosis and atherosclerosis.

참고문헌 (Reference)

1 Jovinge, S., "Tumor necrosis factor-α activates smooth muscle cell migration in culture and is expressed in the ballooninjured rat aorta" 17 : 490-497, 1997

2 Barath, P., "Tumor necrosis factor gene expression in human vascular intimal smooth muscle cells detected by in situ hybridization" 137 : 503-509, 1990

3 Weinberg, R. A., "The retinoblastoma protein and cell cycle control" 81 : 323-330, 1995

4 Sherr, C. J., "The Pezcoller lecture: cancer cell cycles revisited" 60 : 3689-3695, 2000

5 Wei, G. L., "Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty" 80 : 418-426, 1997

6 Horvath, C., "Targeting CCR2 or CD18 inhibits experimental instent restenosis in primates: inhibitory potential depends on type of injury and leukocytes targeted" 90 : 488-494, 2002

7 Galis, Z. S., "Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling" 91 : 852-859, 2002

8 Goetze, S., "TNF-α-induced migration of vascular smooth muscle cells is MAPK dependent" 33 : 183-189, 1999

9 Rayment, N. B., "Synthesis of TNF α and TGF β mRNA in the different microenvironments within atheromatous plaques" 32 : 1123-1130, 1996

10 Abe, J., "Suppression of neointimal smooth muscle cell accumulation in vivo by antisense cdc2 and cdk2 oligonucleotides in rat carotid artery" 198 : 16-24, 1994

11 Schwartz, S. M., "Smooth muscle migration in atherosclerosis and restenosis" 100 : S87-S89, 1997

12 Tanaka, H., "Smooth muscle cells of the coronary arterial tunica media express tumor necrosis factor-α and proliferate during acute rejection of rabbit cardiac allografts" 147 : 617-626, 1995

13 Bendeck, M. P., "Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat" 75 : 539-545, 1994

14 Abedi, H., "Signalling mechanisms in the regulation of vascular cell migration" 30 : 544-556, 1995

15 Tomita, H., "Roxithromycin is an inhibitor of human coronary artery smooth muscle cells proliferation: a potential ability to prevent coronary heart disease" 182 : 87-95, 2005

16 Akiyama, T., "Phosphorylation of the retinoblastoma protein by cdk2" 89 : 7900-7904, 1992

17 Schwartz, S. M., "Perspectives series: cell adhesion in vascular biology. Smooth muscle migration in atherosclerosis and restenosis" 99 : 2814-2816, 1997

18 Okamoto, E., "Perivascular inflammation after balloon angioplasty of porcine coronary arteries" 104 : 2228-2235, 2001

19 Newby, A. C., "Molecular mechanisms in intimal hyperplasia" 190 : 300-309, 2000

20 Cho, A., "Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells" 20 : 2527-2532, 2000

21 Pauly, R. R., "Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation" 75 : 41-54, 1994

22 Dollery, C. M., "Matrix metalloproteinases and cardiovascular disease" 77 : 863-868, 1995

23 Cho, A., "Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury" 91 : 845-851, 2002

24 Kim, H. M., "Inhibitory role of magnolol on proliferative capacity and matrix metalloproteinase-9 expression in TNF-α-induced vascular smooth muscle cells" 7 : 1083-1091, 2007

25 Hansson, G. K., "Inflammation, atherosclerosis, and coronary artery disease" 352 : 1685-1695, 2005

26 Connell-Crowley, L., "G1 cyclin-dependent kinases are sufficient to initiate DNA synthesis in quiescent human fibroblasts" 8 : 65-68, 1998

27 Clausell, N., "Expression of tumour necrosis factor α and accumulation of fibronectin in coronary artery restenotic lesions retrieved by atherectomy" 73 : 534-539, 1995

28 Lim, Y., "Epothilone B inhibits neointimal formation after rat carotid injury through the regulation of cell cycle-related proteins" AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS 321 (321): 648-655, 2007

29 Chung, T. W., "Enhanced expression of matrix metalloproteinase- 9 by hepatitis B virus infection in liver cells" 408 : 147-154, 2002

30 Moon, S. K., "ERK1/2 mediates TNF- α-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-κB and AP-1: Involvement of the ras dependent pathway" 198 : 417-427, 2004

31 Fabunmi, R. P., "Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells" 315 : 335-342, 1996

32 Hoefer, I. E., "Direct evidence for tumor necrosis factor-α signaling in arteriogenesis" 105 : 1639-1641, 2002

33 Badimon, J. J., "Different response to balloon angioplasty of carotid and coronary arteries: effects on acute platelet deposition and intimal thickening" 140 : 307-314, 1998

34 Galis, Z. S., "Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion" 75 : 181-189, 1994

35 Ihling, C., "Concordant upregulation of type II-TGF-β-receptor, the cyclin-dependent kinases inhibitor P27Kip1 and cyclin E in human atherosclerotic tissue: implications for lesion cellularity" 144 : 7-14, 1999

36 Braun-Dullaeus, R. C., "Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3- kinase and mammalian target of rapamycin. Arterioscler" 21 : 1152-1158, 2001

37 Braun-Dullaeus, R. C., "Cell cycle progression: new therapeutic target for vascular proliferative disease" 98 : 82-89, 1998